Literature DB >> 11607932

Chemical genomics: functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism.

T M Willson1, S A Jones, J T Moore, S A Kliewer.   

Abstract

Chemical genomics is the name we have given to the analysis of gene function through use of small molecule chemical tools. Orphan nuclear receptors are ideally suited to this technique of functional analysis, since their activity as transcription factors is regulated by small hydrophobic ligands. GW4064 is a potent and selective nonsteroidal ligand for the nuclear bile acid receptor FXR (NR1H4). Using GW4064 as a chemical tool, we have identified genes regulated by FXR in the liver, including those involved in bile acid synthesis and transport. We have also discovered that PXR (NR1I2) is a lithocholic acid receptor that controls the biosynthesis and metabolism of bile acids. Together FXR and PXR cooperate to control biliary and urinary bile acid excretion. These functions suggest that potent PXR and FXR ligands may offer a new approach to the treatment of cholestatic liver disease. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11607932     DOI: 10.1002/med.1023

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  22 in total

1.  Expression and activation of the farnesoid X receptor in the vasculature.

Authors:  David Bishop-Bailey; Desmond T Walsh; Timothy D Warner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

2.  Chemical genomics: massively parallel technologies for rapid lead identification and target validation.

Authors:  Uli Hacksell; Norman Nash; Ethan S Burstein; Fabrice Piu; Glenn Croston; Mark R Brann
Journal:  Cytotechnology       Date:  2002-01       Impact factor: 2.058

Review 3.  Regulation of the cytosolic sulfotransferases by nuclear receptors.

Authors:  Melissa Runge-Morris; Thomas A Kocarek; Charles N Falany
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

4.  Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.

Authors:  J J Schlezinger; H Puckett; J Oliver; G Nielsen; W Heiger-Bernays; T F Webster
Journal:  Toxicol Appl Pharmacol       Date:  2020-08-19       Impact factor: 4.219

5.  Insights into TOR function and rapamycin response: chemical genomic profiling by using a high-density cell array method.

Authors:  Michael W Xie; Fulai Jin; Heejun Hwang; Seungmin Hwang; Vikram Anand; Mara C Duncan; Jing Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-09       Impact factor: 11.205

6.  Inhibition of endothelin-1-mediated contraction of hepatic stellate cells by FXR ligand.

Authors:  Jiang Li; Ramalinga Kuruba; Annette Wilson; Xiang Gao; Yifei Zhang; Song Li
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

7.  FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states.

Authors:  Jongsook Kim Kemper; Zhen Xiao; Bhaskar Ponugoti; Ji Miao; Sungsoon Fang; Deepthi Kanamaluru; Stephanie Tsang; Shwu-Yuan Wu; Cheng-Ming Chiang; Timothy D Veenstra
Journal:  Cell Metab       Date:  2009-11       Impact factor: 27.287

8.  The first completed genome sequence from a teleost fish (Fugu rubripes) adds significant diversity to the nuclear receptor superfamily.

Authors:  Jodi M Maglich; Justin A Caravella; Millard H Lambert; Timothy M Willson; John T Moore; Lakshman Ramamurthy
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

Review 9.  Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.

Authors:  Hongbing Wang; Edward L LeCluyse
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells.

Authors:  P Martin; R Riley; D J Back; A Owen
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.